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Over 50% of end-stage renal disease (ESRD) patients die of cardiovascular disease. ESRD patients treated with maintenance
hemodialysis are repeatedly exposed to oxidative stress. The aim of the study was to find the relationship between lifestyle
factors, nutritional status, calcium-phosphate metabolism, and selected redox parameters such as glutathione peroxidase (GPx),
glutathione reductase (GR), superoxide dismutase (SOD), uric acid (UA), and total antioxidant capacity expressed as ferric
reducing antioxidant power (FRAP). The study included 97 ESRD hemodialysis patients and 42 controls with no renal disease.
Patients were asked to complete a questionnaire which gathered information on their physical activity, hours of sleep, smoking,
and frequency of fruit and vegetable intake; the blood samples were then drawn before the midweek dialysis session. The ESRD
patients had lower levels of GR, GPx, and SOD activity, a lower level of FRAP, and a higher UA concentration than the control
group. The FRAP value decreased with age (ρ = −0 32, p = 0 001); smokers had a significantly lower SOD activity in comparison
to nonsmokers (p = 0 03). In the ESRD patients, FRAP and UA correlated with both albumin (ρ = 0 26, p = 0 011; ρ = 0 41, p =
0 006, respectively) and prealbumin (ρ = 0 34, p ≤ 0 001; ρ = 0 28, p = 0 006, respectively), whereas UA, GR, GPx, and SOD
correlated with calcium, UA, GR, and GPx with phosphate level. Based on the findings, there are weak associations between
nutritional status and selected redox parameters in hemodialyzed patients. Further studies are needed to establish if diet
modifications and adequate nutritional status can positively impact the antioxidant capacity in this group of patients.
1. Introduction
Over 50% of patients in end-stage renal disease (ESRD)
die of cardiovascular events [1]. In the general population,
traditional risk factors for cardiovascular disease (CVD)
include smoking, hypertension, obesity, and increased LDL
or low HDL cholesterol levels [2]. Patients treated with main-
tenance hemodialysis frequently develop additional compli-
cations which may further exacerbate the progression of
CVD. They include hypoalbuminemia, anaemia, disturbed
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calcium-phosphate metabolism, electrolyte imbalance,
increased sympathetic nervous system activity, and meta-
bolic acidosis [3]. Numerous studies, however, emphasize
that what lies at the root of CVD pathogenesis is oxidative
stress (OS). Hemodialysis patients are especially vulnerable
to redox balance disruption as they are repeatedly exposed
to elevated OS during regular dialysis sessions requiring the
presence of a central venous catheter or an arteriovenous fis-
tula and the use of bioincompatible dialyzers and bloodlines
[4]. It has been shown that OS, by promoting renal ischemia,
may decrease residual diuresis, which is important for the
proper functioning of the CV system. Excessive production
of reactive oxygen species (ROS), especially O2-, leads to
nitric oxide (NO) inactivation and deficiency [5]. NO is a
critical antioxidant that protects kidney function by increas-
ing renal blood flow through blood vessel relaxation. A
decrease in NO concentration is regarded as an early mecha-
nism of atherosclerosis, as it prevents platelet aggregation
and smooth muscle hypertrophy and reduces the expression
of adhesion endothelial molecules [6].
Another problem frequently developed by ESRD patients
which may further disturb redox balance is the malnutrition-
inflammation-atherosclerosis (MIA) syndrome, which indi-
cates the interdependence of atherosclerosis with poor nutri-
tional status and the inflammatory component. Stenvinkel
et al. [7] distinguish two types of malnutrition. The first
one can be reversed with an increase in calorie and protein
supply and is rarely connected with comorbidities. Hemodi-
alysis patients, however, face many dietary restrictions, and
the first type of malnutrition can easily progress into the sec-
ond type characterized by inflammatory background and
markedly elevated OS. Concomitant increase in resting
energy expenditure, the loss of vitamins and microelements
during the hemodialysis procedure, and low intake of fruits
and vegetables—a prominent source of antioxidants—can
thus further disturb redox homeostasis in ESRD patients [5].
Modifiable lifestyle factors (physical activity, diet, sleep
duration, alcohol intake or smoking) may each influence
redox homeostasis [8–13]. ROS are generated in response to
environmental stressors such as cold, viral or bacterial infec-
tions, drugs, toxins, radiation, hypoxia, and hyperoxia [14].
In ESRD patients, kidney filtration is significantly impaired,
which contributes to increased accumulation of uremic toxins
such as indoxyl sulphate, methylguanidine, xanthine, or oro-
tic acid and limited elimination of cytokines and waste prod-
ucts. Increased activity of the mitochondrial transport chain,
degradation of metabolites in lysosomes, peroxisomal lipid
β-oxidation, oxidation of ethanol in the microsomal ethanol
oxidizing system, or cytochrome P-450 detoxication of xeno-
biotics are metabolic processes which can lead to increased
production of ROS causing stress on cellular structures and
inducing changes in molecular pathways [15].
ROS may induce CV pathology by damaging lipids, pro-
teins, and DNA and forming advanced glycation end prod-
ucts (AGEs) which have been shown to accumulate in
atherosclerotic plaques and are thought to activate monocyte
infiltration through NF-κB [14]. What is more, oxidized LDL
can increase expression of peroxisome proliferator activated
receptors (PPAR) in foam cells of atherosclerotic lesions [14].
Equally important is the fact, however, that ROS also reg-
ulate a wide range of processes in the cardiovascular system
and contribute to the maintenance of cardiovascular homeo-
stasis [16]. They can serve as signaling molecules to regulate
physiological processes and act as messengers both in the
extracellular environment and within cells [17–19]. At low
to modest concentrations, they are considered to be essential
for the regulation of cell cycle progression and proliferation,
differentiation, migration, and cell apoptosis [20]. They also
promote the organism’s immune functions and natural
defenses—leukocytes, especially neutrophils, produce oxygen
radicals through NADPH oxidase in the respiratory burst to
protect the host organism from pathogens [8].
ESRD patients are regularly exposed to OS during
hemodialysis sessions. In the study, we investigated the rela-
tionships between redox balance in patients treated with
maintenance hemodialysis and their nutritional status,
inflammation, and iron and calcium-phosphate metabolism.
Also, the impact of selected modifiable lifestyle factors on the
redox balance was assessed.
2. Materials and Methods
2.1. Patients. The cross-sectional study included adult
patients in ESRD treated with maintenance hemodialysis
(3–5h dialysis sessions three times a week). The study group
was recruited at two centres: the Department of Nephrology
of Jagiellonian University Medical College in Krakow, Poland
and the Dialysis Therapy Centre of Clinical District Hospital
No. 2 in Rzeszow, Poland in December 2016 and January
2017. The inclusion criteria were age 18 years or older, ESRD
diagnosis defined according to KDIGO [21], and repeated
maintenance hemodialysis treatment for a period of at least
1 month. Patients were dialyzed using an arteriovenous fis-
tula (82%), a permanent catheter implanted in the jugular
vein (15%), or an acute catheter placed in the subclavian, jug-
ular, or femoral vein (3%). In 78% of the patients, low-flux
dialyzers were used, while the remaining group underwent
hemodiafiltration with high-flux dialyzers. The mean weekly
hemodialysis time was 12 hours ± 30minutes. The adequacy
of the dialysis was evaluated based on clinical symptoms
and the Kt/V index assessed once per month. Most patients
(98.5%) had a Kt/V ≥ 1 2.
In order to assess control values of redox balance labora-
tory tests, a control group was recruited from workers
undergoing routine periodic occupational medicine exami-
nations whose blood samples were examined at the Diag-
nostic Department of the University Hospital in Krakow,
Poland. These persons had GFR > 60mL/min/1 73m2, no
history of renal disease, and no acute health issues, and
their C-reactive protein (CRP) concentration was below
5mg/L. They passed the routine health checkup with no
new diseases diagnosed. Participation in the study was vol-
untary, and each patient gave his/her written consent to
take part in the study. The study protocol had the consent
of the Bioethics Committee of the Regional Medical Cham-
ber in Rzeszow, Poland (approval number 70/2014/B issued
on 19 September 2014).
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2.2. Questionnaire. A self-constructed questionnaire was
administered among hemodialysis patients. It was completed
by the patients on their own or with the author’s assistance
(M.M.) whenever needed. The questionnaire gathered infor-
mation on patients’ physical activity (low/moderate), hours
of sleep (6 hours or less/day, 7-8 h/day, 9 hours or more/day),
frequency of fruit and vegetable intake (one or more por-
tion/day, less than 1 portion/day), and smoking.
2.3. Laboratory Tests. In the study group, hematology and
biochemistry tests including white blood cells (WBC), plate-
let (PLT), iron, total iron binding capacity (TIBC), total
calcium, phosphate, albumin, prealbumin (PRE), and CRP
were performed in the Diagnostic Department of the Univer-
sity Hospital in Krakow, Poland as routine monitoring of
patients. Due to local differences in patient monitoring, lipid
profiles (total cholesterol, LDL cholesterol, HDL cholesterol,
and triglycerides) and iPTH were only available for patients
treated in Rzeszow. Blood samples were collected before the
midweek dialysis session.
The aliquots of serum/plasma were frozen in -80°C and
used for the measurement of parameters associated with
redox balance and nutritional status. In the control group,
aliquots of samples drawn for the routine laboratory tests
were frozen for the purpose of the present study.
The assays used to measure redox balance including
glutathione reductase (GR), glutathione peroxidase (GPx),
superoxide dismutase (SOD), and ferric reducing antioxi-
dant power (FRAP) were conducted at the Department
of Diagnostics of Jagiellonian University Medical College,
Krakow, Poland.
GR activity was evaluated based on the reduction of
oxidized glutathione (GSSG) in the presence of NADPH, oxi-
dized into NADP+ [22]. GPx activity was measured based on
the decrease of NADPH absorbance at 340nm according to
the Paglia and Valentine method [23].
SOD activity was assessed with the Misra and Fridovich
method [24], which involves oxidation of adrenaline to adre-
nochrome in the basic pH environment. The measurement
was conducted at a wavelength of λ = 480 nm. An activity
unit for SOD was defined as an amount of enzyme which
causes 50% inhibition of adrenaline autoxidation.
Total antioxidant capacity was measured using the FRAP
method. Fe3+ ions in the tripyridyltriazine complex (Fe3+-
TPTZ) were reduced by serum low-molecular antioxidants.
The reaction product—Fe2+-TPTZ—has an intense blue
color and presents maximum absorbance at wavelength λ =
593 nm. Antioxidant capacity was assessed through the mea-
surement of absorbance change in the assay and the sample
Fe2+ solution [25].
Nutritional status of the study group was assessed
using body mass index (BMI), based on body mass measure-
ments conducted after the midweek dialysis session and albu-
min, prealbumin, CRP/PRE, and Glasgow Prognostic Score
(GPS). GPS is a useful survival predictor in advanced stages
of cancer as it takes into account both inflammation and mal-
nutrition and has been used also in ESRD. A GPS score value
(0–2) was assigned based on the CRP and albumin concen-
trations (score = 0 if CRP ≤ 10mg/L and albumin ≥ 35 g/L;
score = 1 if CRP > 10mg/L or albumin < 35 g/L; score = 2 if
CRP > 10mg/L and albumin < 35 g/L) [26].
2.4. Statistical Analysis. The number of patients (percentage
of the appropriate group) was reported for categories.
Contingency tables were analyzed with a chi-squared test.
Mean ± standard deviation (SD) and median (lower-upper
quartile) were shown for the quantitative variables with
normal and nonnormal distribution, respectively. The differ-
ences between groups were assessed with the t-test or Mann–
Whitney test, according to distribution. The Spearman rank
coefficient (ρ) was used to study correlations as most vari-
ables were nonnormally distributed. Logistic regression was
used to assess whether differences between the control and
the study group were independent of sex, age, and CRP. Lin-
ear regression was used to verify whether the correlations
between redox and nutritional parameters were independent
of age, dialysis vintage, comorbidities, and inflammation in
ESRD patients; CRP values were log transformed prior to
the analysis as the variable was highly right skewed. The
highly correlated variables (such as albumin and prealbumin
or total and LDL cholesterol) were assessed in separate linear
regression models.
Results were considered significant at p < 0 05. The
analysis was performed with Statistica 12.0 (StatSoft, Tulsa,
OK, USA) software.
3. Results
The study included 97 ESRD patients on maintenance hemo-
dialysis and 42 controls (Table 1). The groups differed in age,
sex, CRP, and nutritional parameters (Table 1). The ESRD
patients were hemodialyzed for a period of 1.5 months to
32 years (Table 2). The lifestyle questionnaire (Table 2)
showed that 17% were active smokers, and less than half
declared a moderate level of physical activity. As much as
39% of the patients consumed fruits and 46% consumed veg-
etables less frequently than once a day. Over 63% of the
patients had calcium levels below the reference range and
over 80% of patients had phosphorus levels above the upper
reference limit (Table 1). Total cholesterol and LDL choles-
terol were above the reference range in about a quarter of
the patients, and 18% had HDL cholesterol below the refer-
ence range. Fifty three percent of the patients had a TIBC
below the lower reference limit (Table 1).
The studied group of ESRD patients differed signifi-
cantly from the controls in all the studied redox parame-
ters: the hemodialysis patients had lower levels of GPx, GR,
and SOD activity, a lower FRAP value, and higher UA con-
centrations than the control group (Table 1). The differences
between patients and controls in terms of GPx, GR, and
FRAP values were significant after adjustment for sex and
age; however, after additional adjustment for CRP, only
GPx and SOD differed significantly between patients and
controls (Table 3).
In ESRD patients, the FRAP values decreased with age
(ρ = 0 32, p = 0 046). A longer duration of maintenance
dialysis treatment was associated with higher FRAP values
(ρ = 0 26, p = 0 014), GR activity (ρ = 0 35, p ≤ 0 001), and
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UA level (ρ = 0 35, p ≤ 0 001). No sex-related differences
were observed in redox parameters in the study group.
In controls, UA increased with age (ρ = 0 41, p = 0 017)
and men and women differed in FRAP value (1 21 ± 0 26,
1 01 ± 0 26; p = 0 019) and UA level (324 8 ± 49 0, 266 8 ±
66 6; p = 0 013), respectively.
The studied redox parameters were intercorrelated both
in the ESRD patients and in controls. In the hemodialyzed
patients, there were statistically significant correlations
between GR and SOD (ρ = −0 23, p = 0 02), GR and biliru-
bin (ρ = 0 39, ≤0 001), GPx and UA (ρ = 0 42, p≤ 0.001),
and FRAP and UA (ρ = 0 47, p ≤ 0 001). In the control
group, FRAP correlated with UA (ρ = 0 81, p ≤ 0 001) and
GR (ρ =0.45, p = 0 004).
In ESRD patients, several correlations were observed
between the nutritional status biomarkers and redox parame-
ters—albumin correlated positively with FRAP and UA; sim-
ilarly, prealbumin correlated with FRAP, GR, and UA. There
was a positive correlation of total cholesterol and LDL
cholesterol with GR (Figure 1). Of those correlations, the
associations between FRAP and prealbumin, UA and albu-
min and prealbumin, as well as GR and prealbumin, total
cholesterol, and LDL cholesterol were independent of age,
dialysis therapy duration, comorbidities, and CRP of ESRD
patients (Table 4). No correlations were observed between
redox and nutritional parameters in the controls. More-
over, in ESRD patients, GPx inversely correlated with PLT
(ρ = −0 41, p ≤ 0 001) and WBC (ρ = −0 27, p = 0 007).
FRAP showed a positive correlation with Fe (ρ = 0 32, p =
0 005) and TIBC (ρ = 0 29, p = 0 012). The associations of
FRAP with Fe (beta 0 29 ± 0 11, p = 0 008) and TIBC (beta
0 31 ± 0 11; p = 0 008) were both independent of age, dialysis
therapy duration, comorbidities, and CRP of ESRD patients.
Significant correlations were observed between redox
parameters and serum concentrations of total calcium and
phosphate (Table 5). UA correlated positively with total
Table 1: Demographic data and selected laboratory results in the ESRD patients and control group.
Laboratory parameters ESRD patients (N = 97) Control group (N = 42) p Reference range
Age (years) 62 ± 14 52 ± 18 ≤0.001 Not applicable
Males (n, %) 60 (61.9) 17 (40.5) 0.023 Not applicable
Albumin (g/L) 39.4 (36.4–42.8) 44.5 (40.3–47.0) <0.001 35–52
Prealbumin (g/L) 0.27 (0.22–0.32) No data — 0.20–0.40
CRP (mg/L) 5.75 (2.2–13.7) 1.45 (1.0–1.4) ≤0.001 <5
PLT (×103/μL) 203 ± 67 4 240 ± 66 0.005 125–340
WBC (×103/μL) 6.5 (5.1–7.8) 5.8 (5.3–6.8) 0.267 4–10
Total cholesterol (mmol/L)∗ 4 2 ± 1 4 5 2 ± 0 8 <0.001 3.2–5.2
LDL cholesterol (mmol/L)∗ 2 3 ± 1 1 2 9 ± 0 9 <0.001 0.2–3.4
HDL cholesterol (mmol/L)∗ 1 0 ± 0 3 1 5 ± 0 4 0.022 0.9–3.0
Triglycerides (mmol/L)∗ 1.5 (1.2–2.2) 1.9 (1.6–2.3) 0.210 0.2–2.3
Bilirubin (μmol/L) 8.5 (6.8–10.3) 10.1 (8.7–17.2) 0.014 0–21
Uric acid (μmol/L) 357 9 ± 107 6 287 94 ± 66 37 ≤0.001 F: 143.0–340.0
M: 202.0–416.0
Total calcium (mmol/L) 1.89 (1.18–2.27) No data — 2.15–2.55
Phosphate (mmol/L) 2.50 (1.65–4.50) No data — 0.81–1.45
iPTH (pg/mL)∗ 174.4 (75.4–410.7) No data — 14.9–56.9
Iron (μmol/L) 11.80 (9.12–15.00) No data — 5.83–34.50
TIBC (μmol/L) 42 2 ± 10 3 No data — 40.8–76.6
GPS
0 (n, %) 56 (57.7) 39 (92.9)
1 (n, %) 25 (25.8) 3 (7.1) <0.001 0
2 (n, %) 11 (11.3) 0
CRP/PRE 0.019 (0.008–0.0587) No data — No data
Glutathione peroxidase (U/L) 75 9 ± 35 8 125 9 ± 18 8 ≤0.001 No data
Glutathione reductase (U/L) 76.7 (66.7–98.3) 100.7 (91.0–111.6) ≤0.001 No data
FRAP (mmol/L) 0 88 ± 0 23 1 10 ± 0 27 0.027 No data
Superoxide dismutase (U/mL) 13.2 (9.8–17.5) 19.4 (13.6–23.9) 0.002 No data
LDL—low-density lipoprotein; HDL—high-density lipoprotein; iPTH—intact parathyroid hormone; PLT—platelet counts; WBC—white blood cells;
TIBC—total iron binding capacity; GPS—Glasgow Prognostic Score; PRE—prealbumin; CRP—C-reactive protein; F—females; M—males; FRAP—ferric
reducing antioxidant power. ∗Due to local differences in patient monitoring, lipid profiles and iPTH were only available for 44 patients treated in Rzeszow,
Poland.
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calcium and inversely with phosphate level. SOD correlated
positively with total calcium, whereas GR and GPx with both
total calcium and phosphate (Table 5). No correlation was
found between the redox parameters and iPTH.
The analysis of lifestyle factors in the ESRD patients
showed that there were no statistically significant differences
in redox parameters between patients declaring low and
those declaring moderate physical activity. Patients eating
at least one portion of fruit per day had a higher UA level
(p = 0 024), similar to those eating at least one portion of veg-
etables per day (p = 0 044). No other significant differences
were observed in relation to fruit and vegetable frequency
intake. No differences were recorded between groups declar-
ing different amounts of sleep daily. SOD was higher in non-
smokers than in smokers (p = 0 027).
4. Discussion
The comparison of redox parameters in the control and the
study group clearly showed that hemodialyzed patients had
a lower activity of endogenous enzymes and FRAP value as
compared to healthy controls. The GPS, which takes into
account albumin and CRP level values, showed that nearly
36% of patients had some degree of malnutrition or inflam-
mation. Malnutrition and hypoalbuminemia reduce antioxi-
dant defense [27], and albumin and prealbumin, commonly
used nutritional markers, possess antioxidant properties
and can account for significantly lower FRAP values when
compared with the controls.
Moreover, FRAP increased with dialysis duration, which
may imply that the increased OS to which patients are
exposed during maintenance hemodialysis sessions induces
a strong compensatory response of antioxidant mechanisms
and reflects the organism’s effort to activate an antioxidant
defense. Nevertheless, the antioxidant capacity diminishes
with age and redox balance appears to be more difficult
to maintain.
Hemodialysis patients are subject to a number of dietary
restrictions (e.g., reduction of phosphorous intake, an impor-
tant component of protein foods); therefore, their overall diet
frequently does not meet daily caloric and protein require-
ments [28]. Moreover, the risk of elevated potassium and
fluid overload, which contribute to severe CV complications
and increased mortality in hemodialysis patients [3], may
lie behind decreased fruit and vegetable consumption in
this group of patients [29]. Meanwhile, fruits and vegeta-
bles supply the organism with low-molecular exogenous
antioxidants and may contribute to the overall antioxidant
capacity of plasma.
An equally important element of defense against free
radicals is the antioxidant system which requires specific
microelements, which can be deficient in a restrictive, low-
calorie diet. An inadequate intake of elements such as copper,
selenium, manganese, or iodine can translate into incorrect
functioning of endogenous enzymes. Extracellular GPx, for
example, is a selenium-dependent enzyme, and extracellular
SOD contains copper and zinc in its structure. Montazerifar
et al. [30] have shown that hemodialysis patients who had
higher intake of fruits and vegetables had a concomitant
increase in SOD activity.
In our study, patients who consumed more fruits and
vegetables had a higher UA level which could be attributed
to an overall higher intake of food and high-purine products.
However, several in vitro and in vivo studies have also shown
that fructose, present in fruits and in moderate amounts in
vegetables, increases blood UA levels [31]. Fructose per se
can also induce oxidative stress as it stimulates mitochondrial
metabolism leading to an increase in ROS production
through an apocynin-sensitive pathway [32]. In our study,
the FRAP value correlated with UA as its estimated total con-
tribution to FRAP is 60% (protein—10%, bilirubin—5%,
ascorbic acid—15%, α-tocopherol—5%, and other com-
pounds—5%) [33]. UA is a powerful oxygen radical scaven-
ger in hydrophilic environments, and a recent study on a
large cohort showed that low and not high serum UA levels
predicted all-cause and CV mortality [34]. Interesting is the
fact that in the control group, despite lower UA, a higher
FRAP value was reported. The hemodialysis patients, on
the other hand, had higher UA but lower FRAP value. This
would mean that in the control group, components other
than UA contribute to the total antioxidant capacity of
plasma, a fact which may be involved with their less restric-
tive diets and better nutritional status.
Table 2: Clinical characteristics and lifestyle factors in the ESRD
patients.
Characteristic ESRD patients (N = 97)
Dialysis therapy duration (months) 63 (36–144)
Smokers (n, %) 17 (17.5)
Comorbid conditions (n, %) 80 (81.6)
Diabetes mellitus (n, %) 25 (25.7)
Hypertension (n, %) 57 (58.8)
Osteoporosis (n, %) 22 (22.7)
Periodontal disease (n, %) 8 (8.2)
Autoimmunological disease (n, %) 4 (4.1)
Sleep
6 hours or less/day (n, %) 32 (33.0)
7-8 h/day (n, %) 48 (49.5)
9 hours or more/day (n, %) 15 (15.5)
Physical activity
Moderate (n, %) 44 (45.4)
Low (n, %) 51 (52.6)
Fruit frequency
≥One portion/day (n, %) 57 (58.8)
<One portion/day (n, %) 36 (37.1)
Vegetable frequency
≥One portion/day (n, %) 50 (51.5)
<One portion/day (n, %) 42 (43.3)
BMI (kg/m2)
Women 24 5 ± 5 8
Men 25 7 ± 4 4
Abbreviations: BMI—body mass index; N—number of patients; ESRD—
end-stage renal disease.
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The analysis of correlations between the nutritional and
redox parameters (Figure 1) showed several relationships,
most of which have been confirmed in multiple linear regres-
sion adjusted for age, dialysis vintage, comorbidities, and
CRP of ESRD patients (Table 4). Nevertheless, the correla-
tions were weak. The most probable explanation is that many
factors may influence both nutritional and redox parameters
measured in serum or plasma, and we have controlled only
for a part of these factors.
As for other lifestyle factors and their impact on redox
parameters, patients who declared active smoking had a lower
SOD activity compared to nonsmokers. The study seems to
be in agreement with other studies by Naga Sirisha and
Manohar [35] and Manafa et al. [36]. Smoking HD patients
Table 3: Differences between ESRD patients and controls assessed by logistic regression adjusted for sex, age, and CRP. Odds ratios (OR) for
being in the study group are reported with 95% confidence intervals (CI).
Adjusted for sex and age Adjusted for sex, age,and CRP
OR (95% CI) p OR (95% CI) p
Glutathione peroxidase (per 1U/L) 0.94 (0.92; 0.98) ≤0.001 0.97 (0.95; 0.98) ≤0.001
Glutathione reductase (U/L) 0.99 (0.97; 0.998) 0.021 1.00 (1.98; 1.02) 0.7
FRAP (mmol/L) 0.10 (0.01; 0.64) 0.016 0.44 (0.06; 3,14) 0.4
Uric acid (per 10 μmol/L) 1.07 (1.02; 1.12) 0.011 1.01 (0.96; 1.06) 0.7
Superoxide dismutase (U/mL) 0.98 (0.95; 1.02) 0.3 0.91 (0.85; 0.97) 0.003
CRP—C-reactive protein; FRAP—ferric reducing antioxidant power.
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Figure 1: Correlations between selected redox and nutritional parameters in ESRD patients: ferric reducing antioxidant power (FRAP) and
prealbumin (a); uric acid (UA) and prealbumin (b); glutathione reductase (GR) and prealbumin (c); FRAP and albumin (d); UA and albumin
(e); GR and total cholesterol (f); GR and LDL cholesterol (g).
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are more prone to oxidative tissue injury than nonsmok-
ing subjects; therefore, smoking cessation is strongly rec-
ommended [4]. What’s more, long-term cigarette smoking
is also a risk factor for impaired endothelium-dependent
relaxation [15].
Physical activity increases metabolic processes and free
radicals are the by-product of intensified mitochondrial pro-
cesses. Acute and strenuous exercise can generate an excess
of free radicals [37]. However, regular moderate exercise
seems to counteract oxidative stress-related detrimental
changes and promote a healthy lifestyle. This idea is summa-
rized by the concept of hormesis defined as the adaptive
response seen in organisms continuously exposed to low to
moderate levels of stress [38]. Under these conditions, cells
develop an adaptive response, including increased expression
of antioxidant genes [39]. The induction of hormesis is
controlled by redox sensor pathways which, upon activa-
tion by oxidants, upregulate the antioxidant enzymatic sys-
tem. For example, intense physical exercise activates the
mitogen-activated protein kinase (MAPK) and the NF-κB
redox signaling pathways. The major targets of these path-
ways are antioxidant enzymes, including SOD, GPx, and
GSH which contain NF-κB and activator protein-1 (AP-1)
binding sites in their promoters as well as responsive elements
to various stimuli like proinflammatory cytokines, oxygen
tension, and ROS [40]. The above study did not show any
association of physical activity level with the tested parame-
ters. The reason for that may be that ESRD patients are fre-
quently bedridden and no strenuous exercise is advised;
however, moderate activity could influence the redox homeo-
stasis and further studies on a larger cohort are warranted.
A considerable challenge in ESRD patients is maintaining
calcium-phosphate balance. Impaired elimination of phos-
phate by the kidneys in ESRD patients has been associated
with vascular calcification and cardiovascular events as
well as induction of secondary hyperparathyroidism, which
is one of the causative agents of increased incidence of CV
complications in the studied population [21]. Phosphate is
mainly a structural component of nucleic acids, adenosine
Table 4: The results of multiple linear regression in ESRD patients showing the associations between the redox and nutritional parameters
that were independent of covariates. Standardized beta coefficients (95% confidence intervals) and p values were shown for dependent
variables, and the coefficients of determination (R2) were shown for the models.
Independent
variable
Dependent variable
FRAP (mmol/L)
Uric acid (μmol/L) Glutathione reductase (U/L)
Model 1 Model 2 Model 1 Model 2 Model 3
Albumin (g/L) Not included
0.45 (0.23; 0.68);
p < 0 001 Not included Not included Not included Not included
Prealbumin
(g/L)
0.26 (0.04; 0.49);
p = 0 026 Not included
0.27 (0.03; 0.51);
p = 0 030
0.27 (0.03; 0.51);
p = 0 032 Not included Not included
Total
cholesterol
(mmol/L)
Not included Not included Not included Not included
0.47 (0.17; 0.77);
p = 0 005 Not included
LDL
cholesterol
(mmol/L)
Not included Not included Not included Not included Not included
0.46 (0.15; 0.76);
p = 0 007
Age (years)
-0.24 (-0.45; -0.03);
p = 0 028
-0.05 (-0.25; 0.16);
p = 0 6
-0.09 (-0.31; 0.13);
p = 0 4
0.12 (-0.11; 0.34);
p = 0 3
0.01 (-0.29; 0.31);
p = 0 9
0.01 (-0.29; 0.31);
p = 0 9
Dialysis
vintage
(months)
0.22 (0.02; 0.42);
p = 0 035
0.23 (0.03; 0.42);
p = 0 026
0.23 (0.02; 0.44);
p = 0 032
0.20 (-0.01; 0.41);
p = 0 07
0.19 (-0.12; 0.50);
p = 0 2
0.25 (-0.06; 0.55);
p = 0 1
Comorbidity
0.20 (0.01; 0.40);
p = 0 049
0.03 (-0.17; 0.23);
p = 0 8
-0.02 (-0.22; 0.19);
p = 0 9
-0.10 (-0.31; 0.12);
p = 0 4
-0.13 (-0.44; 0.18);
p = 0 4
-0.12 (-0.43; 0.19);
p = 0 5
Log
(CRP, mg/L)
0.06 (-0.15; 0.27);
p = 0 6
0.23 (0.03; 0.44);
p = 0 028
0.17 (-0.05; 0.39);
p = 0 1
0.18 (-0.05; 0.51);
p = 0 1
0.03 (-0.28; 0.33);
p = 0 9
0.01 (-0.31; 0.32);
p = 0 9
R2 and p value
for the model
0.25; p < 0 001 0.26; p < 0 001 0.16; p = 0 012 0.13; p = 0 046 0.29; p = 0 048 0.28; p = 0 064
FRAP—ferric reducing antioxidant power.
Table 5: Correlations between the redox parameters and calcium
and phosphate concentrations in the serum of ESRD patients.
Calcium (mmol/L) Phosphate (mmol/L)
Glutathione
peroxidase (U/L)
ρ = −0 29; p = 0 004 ρ = 0 25; p = 0 012
Glutathione
reductase (U/L)
ρ = 0 31; p = 0 002 ρ = −0 28; p = 0 005
FRAP (mmol/L) ρ = 0 20; p = 0 051 ρ = −0 05; p = 0 638
Uric acid (μmol/L) ρ = 0 41; p ≤ 0 001 ρ = −0 42; p ≤ 0 001
Superoxide
dismutase (U/mL)
ρ = 0 24; p = 0 017 ρ < 0 01; p = 0 968
CRP (mg/L) ρ = 0 01; p = 0 847 ρ = −0 05; p = 0 629
CRP—C-reactive protein; FRAP—ferric reducing antioxidant power.
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triphosphate (ATP), and the phospholipids of membranes,
but it is also necessary for the phosphorylation of nicotin-
amide adenine dinucleotide (NAD). The reduced form
(NADPH) is a unique provider of reducing equivalents to
maintain or regenerate the cellular detoxifying and antiox-
idative defense systems; NADP+, on the other hand, has
acquired signaling functions [40]. Recent studies have shown
that elevated extracellular phosphate concentrations cause
mitochondrial OS by increasing the mitochondrial mem-
brane potential, leading to caspase activation and the subse-
quent induction of apoptosis [41, 42]. Alteration in the
levels of extracellular inorganic phosphate (Pi) triggers sig-
naling to regulate gene expression and cellular functions in
some types of cells [43]. In extraskeletal tissues, it results
in the calcification associated with the upregulation of
osteoblast marker genes in vascular smooth muscle cells.
An increase in extracellular Pi triggers signal transduction
via the PiT1 type III sodium-phosphate cotransporter and
ERK1/2 pathway [43, 44]. What is becoming increasingly
apparent is that there are significant interactions between cal-
cium and redox species, such as superoxide anion (O2-),
hydrogen peroxide (H2O2), and hydroxyl radicals (HO
-)
and that these interactions modify a variety of proteins that
participate in signaling transduction pathways and in other
fundamental cellular functions that determine cell life or
death [45]. Interactions can be considered bidirectional—-
ROS can regulate cellular calcium signaling, whereas calcium
signaling is essential for ROS production [46].
The results show that there is an inverse relationship
between GPx and GR and total calcium and phosphate,
respectively, as well as SOD and total calcium, which shows
some degree of association between endogenous enzymes
and calcium-phosphate metabolism. No correlation was
found between the redox parameters and iPTH. This may
be due to the medication administered to patients according
to KDIGO 2017 guidelines (phosphate binders, calcimi-
metics, and active form of vitamin D) [21] in order to limit
the harmful influence of secondary hyperparathyroidism on
the CV system.
4.1. The Limitations of the Study. Our study has several
limitations. The number of subjects included may limit the
ability to detect the weak associations of the systemic levels
of redox parameters with the lifestyle factors. The question-
naire used to assess physical activity and fruits and vegetables
included only two or three variable questions. A 24-hour die-
tary recall would allow for a more accurate evaluation of a
patient’s diet; however, our questionnaire was designed in a
way that could be easily (and thus willingly) used by hemo-
dialyzed patients. Moreover, the design of the study does
not allow assessing the causality of the observed associations.
5. Conclusion
ESRD patients are inevitably exposed to OS during regular
dialysis sessions. With longer durations of dialysis, compen-
satory mechanisms may be induced to maintain redox bal-
ance. Nevertheless, OS resistance diminishes with age and
in consequence, redox homeostasis is significantly disturbed.
Our results imply that nutritional status is associated with the
redox balance, although the associations are weak and most
possibly affected (or driven) by multiple factors. The lifestyle
factors, such as smoking, can affect redox parameters and
should be taken into account in hemodialysis patients’ treat-
ment. However, larger studies and longitudinal observation
are necessary to assess whether (and to what extent) the life-
style factors may modify the redox balance in hemodialyzed
ESRD patients, and what is the causality of nutritional
status-redox balance associations.
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